Jon P. Stonehouse

2017

In 2017, Jon P. Stonehouse earned a total compensation of $3.9M as President, Chief Executive Officer and Director at BioCryst Pharmaceuticals, a 209% increase compared to previous year.

Compensation breakdown

Bonus$243,019
Non-Equity Incentive Plan$220,862
Option Awards$2,910,080
Salary$532,823
Other$14,405
Total$3,921,189

Stonehouse received $2.9M in option awards, accounting for 74% of the total pay in 2017.

Stonehouse also received $243K in bonus, $220.9K in non-equity incentive plan, $532.8K in salary and $14.4K in other compensation.

Rankings

In 2017, Jon P. Stonehouse's compensation ranked 2,621st out of 14,666 executives tracked by ExecPay. In other words, Stonehouse earned more than 82.1% of executives.

ClassificationRankingPercentile
All
2,621
out of 14,666
82nd
Division
Manufacturing
907
out of 5,772
84th
Major group
Chemicals And Allied Products
240
out of 2,075
88th
Industry group
Drugs
184
out of 1,731
89th
Industry
Biological Products, Except Diagnostic Substances
34
out of 313
89th
Source: SEC filing on May 10, 2018.

Stonehouse's colleagues

We found four more compensation records of executives who worked with Jon P. Stonehouse at BioCryst Pharmaceuticals in 2017.

2017

William Sheridan

BioCryst Pharmaceuticals

Chief Medical Officer

2017

Thomas Staab

BioCryst Pharmaceuticals

Chief Financial Officer

2017

Yarlagadda Babu

BioCryst Pharmaceuticals

Senior Vice President of Drug Discovery

2017

Lynne Powell

BioCryst Pharmaceuticals

Senior Vice President and Chief Commercial Officer

News

In-depth

You may also like